Dana Farber Cancer Institute/ Boston Children's Hospital — Boston, Massachusetts

Dana Farber Cancer Institute/ Boston Children's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute/ Boston Children's Hospital has participated in 2 clinical trials.

Therapeutic areas: Hematological Malignancies, Relapsed Solid Tumor, Refractory Solid Tumor.

Sponsors: Gilead Sciences, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute/ Boston Children's Hospital?

Dana Farber Cancer Institute/ Boston Children's Hospital has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute/ Boston Children's Hospital conducted?

Dana Farber Cancer Institute/ Boston Children's Hospital has 2 clinical trials on record. Their work covers Hematological Malignancies, Relapsed Solid Tumor, Refractory Solid Tumor.

Is Dana Farber Cancer Institute/ Boston Children's Hospital accredited by Crixeo Health?

Dana Farber Cancer Institute/ Boston Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute/ Boston Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.